- Home
- Publications
- Publication Search
- Publication Details
Title
Bromodomain Drug Discovery – the Past, the Present, and the Future
Authors
Keywords
-
Journal
CHEMICAL RECORD
Volume 18, Issue 12, Pages 1808-1817
Publisher
Wiley
Online
2018-10-06
DOI
10.1002/tcr.201800074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
- (2017) Léa Bouché et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins
- (2017) Niall Igoe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development
- (2017) Victoria Jeffers et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics
- (2017) Stuart W. Ember et al. MOLECULAR CANCER THERAPEUTICS
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
- (2017) Amy E. Campbell et al. Skeletal Muscle
- Discovery of a PCAF Bromodomain Chemical Probe
- (2016) Moses Moustakim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Abstract 14: A switch in metabolic phenotype in vemurafenib-resistant melanoma cells to increased amino acid dependence serves as an alternate mechanism for survival
- (2016) Deeba N. Syed et al. CANCER RESEARCH
- BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
- (2016) Guillaume Andrieu et al. CANCER RESEARCH
- The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease
- (2016) Marco Magistri et al. Current Alzheimer Research
- A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors
- (2016) C. Massard et al. EUROPEAN JOURNAL OF CANCER
- First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies
- (2016) S. Postel-Vinay et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of bromodomain factor 3 inTrypanosoma cruzi(TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors
- (2016) Victoria Lucia Alonso et al. FEBS Journal
- Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways
- (2016) Matthew A. Lalli et al. HUMAN MOLECULAR GENETICS
- Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells
- (2016) Malihe Eskandarpour et al. JOURNAL OF IMMUNOLOGY
- Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
- (2016) Laetitia J. Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
- (2015) Bhavatarini Vangamudi et al. CANCER RESEARCH
- A Plasmodium Falciparum Bromodomain Protein Regulates Invasion Gene Expression
- (2015) Gabrielle A. Josling et al. Cell Host & Microbe
- The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- (2015) M. Boi et al. CLINICAL CANCER RESEARCH
- Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
- (2015) Peiling Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC)
- (2015) Geoffrey I. Shapiro et al. MOLECULAR CANCER THERAPEUTICS
- ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
- (2015) Yang Luo et al. Gastroenterology Research and Practice
- Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
- (2015) Gong-Quan Li et al. Oncotarget
- Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome
- (2015) Danae Schulz et al. PLOS BIOLOGY
- The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts
- (2014) Kerstin Klein et al. ANNALS OF THE RHEUMATIC DISEASES
- BET bromodomain proteins are required for glioblastoma cell proliferation
- (2014) Chiara Pastori et al. Epigenetics
- The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
- (2014) Stuart J. Gallagher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
- (2014) Duncan A. Hay et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
- (2014) Lei Gu et al. NATURE GENETICS
- BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
- (2014) Joydeep Bhadury et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- BET bromodomain inhibition suppresses TH17-mediated pathology
- (2013) Deanna A. Mele et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
- BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
- (2013) Jessica I. Spiltoir et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- ChromoHub: a data hub for navigators of chromatin-mediated signalling
- (2012) L. Liu et al. BIOINFORMATICS
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- Small-Molecule Inhibition of BRDT for Male Contraception
- (2012) Martin M. Matzuk et al. CELL
- BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
- (2012) Camellia Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma
- (2010) Davit Mosashvilli et al. CANCER SCIENCE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Regulation of Cellular Metabolism by Protein Lysine Acetylation
- (2010) S. Zhao et al. SCIENCE
- ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
- (2009) M. Ciro et al. CANCER RESEARCH
- Regulation of Aurora B Expression by the Bromodomain Protein Brd4
- (2009) J. You et al. MOLECULAR AND CELLULAR BIOLOGY
- A complex t(1;22;11)(q44;q13;q23) translocation causingMLL-p300fusion gene in therapy-related acute myeloid leukemia
- (2008) Hiroaki Ohnishi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started